Joint Gavi, WHO, United Against Rabies (UAR) News Release : Gavi to boost access to life-saving human rabies vaccines in over 50 countries: Gavi, WHO and UAR
Geneva---Gavi, the Vaccine Alliance, in collaboration with partners, is announcing support for human rabies vaccines for post exposure prophylaxis (PEP) as part of routine immunisation. Eligible countries are receiving guidance on how to access these vaccines under Gavi’s cofinancing policy. The first round of applications will be accepted by mid- July 2024. Ninety-five percent of […]
Disease Outbreak News: Avian Influenza A (H9N2) - India
On 22 May 2024, the International Health Regulations (IHR) National Focal Point (NFP) for India reported to WHO a case of human infection with avian influenza A(H9N2) virus detected in a child resident of West Bengal state in India. This is the second human infection of avian influenza A(H9N2) notified to WHO from India, with […]
European Commission approves Roche’s Alecensa as the first and only targeted adjuvant treatment for people with ALK-positive early-stage lung cancer
Alecensa reduced the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive resected non-small cell lung cancer, as demonstrated in the Phase III ALINA study Alecensa’s approval addresses an urgent unmet need in the early-stage setting where about half of all people experience disease recurrence following surgery, despite adjuvant chemotherapy […]
Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization
The test uses highly sensitive PCR technology, requiring only a single nasal-swab sample to provide rapid, accurate qualitative detection and differentiation among four of the most prevalent respiratory viruses for which differential diagnosis can drive appropriate treatment. AEnables healthcare professionals to make confident clinical decisions and promptly determine appropriate treatment, with definitive results reported in […]
Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization
The test uses highly sensitive PCR technology, requiring only a single nasal-swab sample to provide rapid, accurate qualitative detection and differentiation among four of the most prevalent respiratory viruses for which differential diagnosis can drive appropriate treatment. AEnables healthcare professionals to make confident clinical decisions and promptly determine appropriate treatment, with definitive results reported in […]
ABHA's Scan and Share Service Facilitates 3 Crore OPD Registrations Nationwide
The National Health Authority (NHA) has achieved a significant milestone in its mission towards digitizing healthcare services with the generation of over 3 crore tokens for Out-Patient Department (OPD) registrations through the ABHA-based Scan and Share service. Launched under the Ayushman Bharat Digital Mission (ABDM) in October 2022, this innovative paperless service has revolutionized the […]
Union Health Ministry reiterates the need for adhering to strict compliance of regulatory protocols and fire-safety norms in meeting with States/UTs and Healthcare Organizations
Safety and wellbeing of patients (both outpatients and inpatients), staff and visitors is of utmost importance in any healthcare facilities. Recently, fire-incidents have been reported in a few places. These are a result of short-circuits due to sub-optimal electrical maintenance and/or overload of electricity lines due to use of Air-Conditioners and other equipment. Given the […]
India hosts side event on Women, Children and Adolescent Health in collaboration with Norway, UNICEF, UNFPA and PMNCH at the 77th World Health Assembly at Geneva
During the ongoing 77th World Health Assembly, India hosted a side event on Women, Children and Adolescent Health in collaboration with Norway, United Nations Children’s Fund (UNICEF), United Nations Population Fund (UNFPA) and Partnership for Maternal, Newborn and Child Health (PMNCH). The purpose of the event was to share emerging evidence and discoveries, fostering dialogue […]
FDA grants Priority Review to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options. Additional analyses of INAVO120 will be presented in an oral abstract session at the 2024 American Society of Clinical Oncology Annual Meeting. The target action date for the FDA decision is 27 November, 2024. Basel, 29 […]
India hosts side event on Digital Health at the 77th World Health Assembly at Geneva
During the ongoing 77th World Health Assembly, India hosted a side event on Digital health which saw participation by the Quad countries (Australia, Japan and the United States of America). The purpose of the event was to emphasize the transformative potential of Digital Public Infrastructure for Addressing Social Determinants of Health. It was attended by […]
